• Publications
  • Influence
Pharmacology of BMY 20064, a potent Ca2+ entry blocker and selective α1-adrenoceptor antagonist
BMY 20064 is a dihydropyridine Ca2+ entry blocker with potent and selective alpha 1-adrenoceptor antagonist properties. The drug was equal in potency to nifedipine as a Ca2+ entry blocker in
BMY 20064, a potent calcium channel blocker with. cap alpha. /sub 1/-adrenoceptor antagonist properties
BMY 20064 ((3-(4-(2-methoxyphenyl)-1-piperazinyl)propyl)-methyl 1,4-dihydro-2-6-dimethyl-4-(3-nitrophenyl)-3-5-pyridinedicarboxylate) is a new Ca/sup +2/ channel blocking agent equivalent in activity